Driggers Rita W, Baschat Ahmet
J Matern Fetal Neonatal Med. 2012 Jan;25(1):3-4. doi: 10.3109/14767058.2012.626917.
The Diabetes in Pregnancy Study Group of North America (DPSG-NA) held its 12th meeting April 1-2, 2011 in Washington DC. The meeting, which was co-hosted by the Washington Hospital Center and the University of Maryland School of Medicine focused on five broad themes: (i) the prevention of diabetes and its risk factors, such as obesity, in pregnancy; (ii) the appropriate use of pharmacotherapies for managing diabetes in pregnancy; (iii) optimal glycemic control; (iv) the value of nutrition, exercise and limiting weight gain during pregnancy and (v) the diagnosis and consequences of diabetic fetopathy. These proceedings reflect peer-reviewed papers of data presented at the meeting. Time also was allocated to discuss the perceived barriers to using the one-step, 75 g oral glucose tolerance test as the first-line approach to diagnosing gestational diabetes mellitus. Responses from a survey of participants on perceived barriers to adopting this method into widespread clinical practice are discussed.
北美妊娠糖尿病研究组（DPSG-NA）于2011年4月1日至2日在华盛顿特区召开了第12次会议。此次会议由华盛顿医院中心和马里兰大学医学院共同主办，聚焦于五个广泛的主题：（i）孕期糖尿病及其危险因素（如肥胖）的预防；（ii）孕期糖尿病管理中药物治疗的合理使用；（iii）最佳血糖控制；（iv）孕期营养、运动及限制体重增加的价值；（v）糖尿病胎儿病的诊断及后果。这些论文集反映了在会议上发表的经过同行评审的数据论文。会议还安排时间讨论了将一步法75克口服葡萄糖耐量试验作为诊断妊娠期糖尿病的一线方法所面临的公认障碍。文中讨论了对参会者关于将该方法应用于广泛临床实践所面临的公认障碍的调查结果。
